| Consider the context: Ras/ERK and PI3K/AKT/mTOR signaling outcomes are pituitary cell type-specific AK Roof, A Gutierrez-Hartmann Molecular and Cellular Endocrinology 463, 87-96, 2018 | 40 | 2018 |
| The balance of PI3K and ERK signaling is dysregulated in prolactinoma and modulated by dopamine AK Roof, S Jirawatnotai, T Trudeau, C Kuzyk, ME Wierman, H Kiyokawa, ... Endocrinology 159 (6), 2421-2434, 2018 | 21 | 2018 |
| Mouse models for the analysis of gonadotropin secretion and action SB Gilbert, AK Roof, TR Kumar Best Practice & Research Clinical Endocrinology & Metabolism 32 (3), 219-239, 2018 | 10 | 2018 |
| Pituitary somatolactotropes evade an oncogenic response to Ras AK Roof, T Trudeau, A Gutierrez-Hartmann Molecular and cellular endocrinology 476, 165-172, 2018 | | 2018 |
| Cell Cycle Progression Antagonizes ERK-Mediated PRL Promoter Activity Via PI3K/CDK4 AK Roof, T Trudeau, A Gutierrez-Hartmann 99th Annual Meeting of the Endocrine Society, 2017 | | 2017 |
| The Balance of Ras/ERK and PI3K/AKT/mTOR Signaling Regulates Pituitary Lactotrope Homeostasis and is Dysregulated in Prolactinoma AK Roof University of Colorado, 2017 | | 2017 |
